Olympus-backed PAI Pharma picks up Nivagen Pharmaceuticals

Headquartered in Greenville, South Carolina, PAI is a developer, manufacturer and marketer of oral liquid medicines.

6 January 2026•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.